- Home
- OTLK vs GORO Comparison
OTLK vs GORO Comparison
Compare OTLK & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- GORO
- Stock Information
- Founded
- OTLK 2010
- GORO 1998
- Country
- OTLK United States
- GORO United States
- Employees
- OTLK N/A
- GORO N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- GORO Precious Metals
- Sector
- OTLK Health Care
- GORO Basic Materials
- Exchange
- OTLK Nasdaq
- GORO Nasdaq
- Market Cap
- OTLK 48.3M
- GORO 49.9M
- IPO Year
- OTLK 2016
- GORO N/A
- Fundamental
- Price
- OTLK $1.53
- GORO $0.56
- Analyst Decision
- OTLK Strong Buy
- GORO Strong Buy
- Analyst Count
- OTLK 5
- GORO 1
- Target Price
- OTLK $10.20
- GORO $1.25
- AVG Volume (30 Days)
- OTLK 274.9K
- GORO 3.7M
- Earning Date
- OTLK 05-19-2025
- GORO 05-20-2025
- Dividend Yield
- OTLK N/A
- GORO N/A
- EPS Growth
- OTLK N/A
- GORO N/A
- EPS
- OTLK N/A
- GORO N/A
- Revenue
- OTLK N/A
- GORO $65,726,000.00
- Revenue This Year
- OTLK N/A
- GORO $68.69
- Revenue Next Year
- OTLK $288.46
- GORO $19.92
- P/E Ratio
- OTLK N/A
- GORO N/A
- Revenue Growth
- OTLK N/A
- GORO N/A
- 52 Week Low
- OTLK $0.87
- GORO $0.12
- 52 Week High
- OTLK $9.25
- GORO $0.74
- Technical
- Relative Strength Index (RSI)
- OTLK 55.94
- GORO 56.48
- Support Level
- OTLK $1.35
- GORO $0.58
- Resistance Level
- OTLK $1.62
- GORO $0.64
- Average True Range (ATR)
- OTLK 0.10
- GORO 0.06
- MACD
- OTLK -0.00
- GORO 0.01
- Stochastic Oscillator
- OTLK 54.55
- GORO 66.94
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.